LAVAL, Quebec (AP) _ Bellus Health Inc. (BLUSF) on Wednesday reported a loss of $3.6 million in its first quarter.
The Laval, Quebec-based company said it had a loss of 2 cents per share.
The drug developer posted revenue of $6,800 in the period. Its adjusted revenue was $7,000.
The company's shares closed at $1.03. A year ago, they were trading at 46 cents.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLUSF at https://www.zacks.com/ap/BLUSF